Literature DB >> 24925887

Tests for equivalence of two survival functions: Alternative to the tests under proportional hazards.

Elvis E Martinez1, Debajyoti Sinha1, Wenting Wang2, Stuart R Lipsitz3, Richard J Chappell4.   

Abstract

For either the equivalence trial or the non-inferiority trial with survivor outcomes from two treatment groups, the most popular testing procedure is the extension (e.g., Wellek, A log-rank test for equivalence of two survivor functions, Biometrics, 1993; 49: 877-881) of log-rank based test under proportional hazards model. We show that the actual type I error rate for the popular procedure of Wellek is higher than the intended nominal rate when survival responses from two treatment arms satisfy the proportional odds survival model. When the true model is proportional odds survival model, we show that the hypothesis of equivalence of two survival functions can be formulated as a statistical hypothesis involving only the survival odds ratio parameter. We further show that our new equivalence test, formulation, and related procedures are applicable even in the presence of additional covariates beyond treatment arms, and the associated equivalence test procedures have correct type I error rates under the proportional hazards model as well as the proportional odds survival model. These results show that use of our test will be a safer statistical practice for equivalence trials of survival responses than the commonly used log-rank based tests.

Entities:  

Keywords:  Cox’s model; clinical importance; critical region; proportional odds survival model

Mesh:

Year:  2016        PMID: 24925887      PMCID: PMC5557049          DOI: 10.1177/0962280214539282

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  7 in total

1.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.

Authors: 
Journal:  JAMA       Date:  2000-12-20       Impact factor: 56.272

2.  Design and analysis of non-inferiority mortality trials in oncology.

Authors:  Mark Rothmann; Ning Li; Gang Chen; George Y H Chi; Robert Temple; Hsiao-Hui Tsou
Journal:  Stat Med       Date:  2003-01-30       Impact factor: 2.373

3.  A log-rank test for equivalence of two survivor functions.

Authors:  S Wellek
Journal:  Biometrics       Date:  1993-09       Impact factor: 2.571

4.  How to establish equivalence when data are censored: a randomized trial of treatments for B non-Hodgkin lymphoma.

Authors:  C Com-Nougue; C Rodary; C Patte
Journal:  Stat Med       Date:  1993-07-30       Impact factor: 2.373

5.  Analysis of survival data by the proportional odds model.

Authors:  S Bennett
Journal:  Stat Med       Date:  1983 Apr-Jun       Impact factor: 2.373

6.  Influence of unrecognized molecular heterogeneity on randomized clinical trials.

Authors:  Rebecca A Betensky; David N Louis; J Gregory Cairncross
Journal:  J Clin Oncol       Date:  2002-05-15       Impact factor: 44.544

7.  An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer.

Authors:  David J Adelstein; Yi Li; George L Adams; Henry Wagner; Julie A Kish; John F Ensley; David E Schuller; Arlene A Forastiere
Journal:  J Clin Oncol       Date:  2003-01-01       Impact factor: 44.544

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.